Humacyte is the developer of a biotechnology platform designed to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Register for Details

For more details on financing and valuation for Humacyte, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Humacyte's ticker symbol?


What is Humacyte's stock price?

2.88 as of 9/22/23

Learn more about Humacyte

Forge green plus iconForge green minus icon

What is Humacyte funding to date?

Humacyte has raised $440MM to date.
Forge green plus iconForge green minus icon

When was Humacyte founded?

Humacyte was founded in 2004.
Updated on: Jun 12, 2022